# Comparison of Two Basal Insulin Therapies for Patients With Type 1 Diabetes

> **NCT00487240** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 387 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** Insulin Lispro Protamine Suspension
- **DRUG:** Insulin Levemir

## Key facts

- **NCT ID:** NCT00487240
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 387 (ACTUAL)
- **Last updated:** 2010-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00487240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00487240, "Comparison of Two Basal Insulin Therapies for Patients With Type 1 Diabetes". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00487240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*